Ketamine does go bad, but not on a single fixed schedule. The molecule itself is relatively robust, yet the product can fail through microbial contamination, preservative loss, concentration drift, and pH change long before the active ingredient meaningfully decomposes. A sealed vial stored correctly is generally usable until its labeled expiration date; an opened or compounded vial degrades on a much shorter, route-dependent clock. What follows explains the chemistry behind that difference, the numbers that matter, and the practical thresholds clinicians and handlers actually use.

The molecule is more stable than the vial

Ketamine is a cyclohexanone derivative with a chiral center, and its hydrochloride salt is freely water-soluble and chemically sturdy in the pH range of pharmaceutical solutions. The degradation pathways that matter are slow: hydrolysis of the ketone is not favored under normal storage, and the main risks are photochemical change and reactions at extreme pH. This is why manufacturers can assign multi-year shelf lives to unopened product without refrigeration.

The weak link is the formulation. Multidose vials contain a preservative, typically benzalkonium chloride, whose concentration can fall as the vial is repeatedly punctured and as the solution contacts air and rubber. Preservative loss does not change the ketamine concentration, so a chemical assay can look perfect while the antimicrobial protection has quietly eroded. That gap between chemical stability and microbiological safety is the core reason "does ketamine go bad" has no single answer.

Plain language: the drug holds up well, but the container and the handling decide whether you can still trust it.

What actually degrades, and how fast

Three processes drive real-world failure, and they run on different clocks.

Chemical degradation is the slowest. Ketamine HCl in a properly sealed, light-protected container at room temperature loses potency gradually, and stability studies supporting approved shelf lives typically show retention well above the pharmacopeial limit across the labeled period. The limit that matters is potency: United States Pharmacopeia conventions generally treat retention below 90 percent of labeled strength as the failure point, though the exact specification is set by the product's own monograph and label.

Microbial ingress is faster and less predictable. Every needle puncture of a multidose vial creates a channel. Preservative slows growth but does not sterilize an introduced inoculum, and organisms that form biofilms or tolerate benzalkonium chloride can survive. Contamination is invisible; a clear solution proves nothing.

Physical and photochemical change is variable. Ketamine solutions are typically clear and colorless, and discoloration or particulates signal a problem regardless of assay value. Exposure to strong light and to pH extremes accelerates degradation, which is why labels specify protection from light.

A counterintuitive detail: a vial can pass a potency test and still be unsafe, because the assay does not measure sterility or preservative effectiveness. Chemical integrity and microbiological integrity are separate questions, and only the first is easy to check.

Shelf life versus in-use life: two different clocks

The expiration date on the label applies to the unopened container stored as directed. It says nothing about a vial that has been punctured, a syringe that has been drawn, or a compounded solution transferred to a new container. Those are in-use questions, and the clock resets.

For multidose vials, the manufacturer's labeled in-use period governs, and where the label is silent, professional compounding standards set the default. United States Pharmacopeia General Chapter 797 assigns beyond-use dates by risk category and storage condition rather than by drug, which is why the same ketamine vial can carry different practical limits depending on where and how it is handled. A vial punctured in an ISO Class 5 environment under strict aseptic technique is treated differently from one accessed on a ward.

The timeline below summarizes the practical time course for a typical preservative-containing multidose vial. Treat the entries as categories, not as a universal rule, because the label and your facility's policy control.

Stage What is happening Practical implication
Unopened, stored as labeled Slow chemical change only Use until labeled expiration
First puncture Preservative begins to be challenged Record date opened
Early in-use period Preservative effective if technique good Acceptable within labeled or USP 797 limit
Late in-use period Preservative margin narrows Discard at the stated beyond-use date
Visible change at any stage Discoloration or particulate Discard immediately, do not assay
Post-expiration Potency and sterility both unreliable Do not use

The thresholds, reconciled

Different sources give different numbers because they answer different questions, and conflating them causes most of the confusion.

The labeled expiration date answers: how long is the sealed product guaranteed to meet specification? It is set by the manufacturer from stability data and is the only threshold that applies to an untouched vial.

The USP 797 beyond-use date answers: how long may a punctured or compounded preparation be used given its risk category and storage? It is a sterility and handling standard, not a potency standard.

The 90 percent potency convention answers: at what point is the active ingredient no longer within normal assay limits? It applies to the drug substance and product, not to your specific opened vial.

A professional caveat worth stating plainly: none of these thresholds is validated for every container, every climate, and every handling pattern. When the label and the compounding standard disagree, the more conservative limit protects the patient, and facility policy should resolve the conflict before it arises at the bedside.

Red flags that override any date

Visible discoloration, cloudiness, or particles in a solution that should be clear and colorless. A vial whose rubber stopper is torn, coring, or visibly contaminated. Any vial of unknown origin, unlabeled concentration, or broken seal. Product stored outside its labeled temperature range, including accidental freezing of a solution not labeled for it. A multidose vial past its in-use beyond-use date even if the expiration date is far away.

Each of these is a stop signal. None of them can be cleared by a potency assay, because the assay does not address sterility, particulate load, or preservative function.

Misconceptions that persist

The most common error is treating the expiration date as a sterility guarantee for an opened vial. It is not. The date describes the sealed container.

A second error is assuming refrigeration always extends life. Cold storage can slow chemical degradation, but it can also promote precipitation or phase change in some formulations and does nothing to reverse preservative loss. Follow the label; do not improvise storage conditions.

A third is trusting appearance. A contaminated solution is usually clear. Visual inspection catches gross failure, not the failure that matters most.

A fourth is extrapolating from one product to another. A preservative-free preparation, a compounded solution, and a manufactured multidose vial have different stability and handling profiles, and a rule that fits one can be wrong for another.

A fifth, subtler error: assuming that because the molecule is stable, the product is durable. The two are not the same claim, and the gap between them is where most real-world problems occur.

Practical actions and thresholds

Use these steps to make the decision concrete.

Check the label first for storage conditions, in-use limits, and any light-protection requirement. Record the date and time a multidose vial is first punctured, every time.

Apply the correct clock. Unopened product follows the expiration date. Punctured product follows the labeled in-use period or, where the label is silent, your facility's USP 797-based policy. Compounded preparations follow the assigned beyond-use date for their risk category and storage.

Inspect before every use under good light against a dark and a light background. Reject any discoloration, haze, or particulate, and reject any container with a compromised seal or stopper.

Store as directed, protect from light where required, and never freeze a product not labeled for freezing. Keep opened vials out of uncontrolled environments.

Discard at the stated limit even if solution remains. The cost of a discarded vial, often tens of USD for a small multidose container, is trivial against the cost of a contaminated injection.

When in doubt, discard. There is no bedside test that converts an uncertain vial into a certain one.

What the evidence can and cannot tell you

What is well established: ketamine HCl is chemically stable in properly formulated, sealed, light-protected containers, and approved shelf lives reflect that. What is also established: preservative-containing multidose vials carry real contamination risk once punctured, and beyond-use dating exists to manage it.

What is not established with precision: a universal in-use limit that fits every product, setting, and handling pattern. The honest answer to how long an opened vial stays good is that it depends on the formulation, the technique, and the policy that applies, which is why the label and the compounding standard, not a rule of thumb, should govern.

This article does not provide dosing, treatment, or patient-specific guidance. For clinical decisions, follow the product label and your institution's protocols.